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Abstract Although pulmonary hypertension (PH) selec-
tively overloads the right ventricle (RV), neuroendocrine
activation and intrinsic myocardial dysfunction have been
described in the left ventricle (LV). In order to establish the
timing of LV dysfunction development in PH and to clarify
underlying molecular changes, Wistar rats were studied 4
and 6 weeks after subcutaneous injection of monocrotaline
(MCT) 60 mg/kg (MCT-4, n = 11; MCT-6, n = 11) or
vehicle (Ctrl-4, n = 11; Ctrl-6, n = 11). Acute single beat
stepwise increases of systolic pressure were performed
from baseline to isovolumetric (LVPiso). This hemody-
namic stress was used to detect early changes in LV
performance. Neurohumoral activation was evaluated by
measuring angiotensin-converting enzyme (ACE) and
endothelin-1 (ET-1) LV mRNA levels. Cardiomyocyte
apoptosis was evaluated by TUNEL assay. Extracellular
matrix composition was evaluated by tenascin-C mRNA
levels and interstitial collagen content. Myosin heavy chain
(MHC) composition of the LV was studied by protein
quantification. MCT treatment increased RV pressures and
RV/LV weight ratio, without changing LV end-diastolic
pressures or dimensions. Baseline LV dysfunction were
present only in MCT-6 rats. Afterload elevations prolonged
s and upward-shifted end-diastolic pressure dimension
relations in MCT-4 and even more in MCT-6. MHC-iso-
form switch, ACE upregulation and cardiomyocyte
apoptosis were present in both MCT groups. Rats with
severe PH develop LV dysfunction associated with ET-1
and tenascin-C overexpression. Diastolic dysfunction,
however, could be elicited at earlier stages in response to
hemodynamic stress, when only LV molecular changes,
such as MHC isoform switch, ACE upregulation, and
myocardial apoptosis were present.
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Introduction
Although chronic pulmonary hypertension (PH) selectively
overloads the right ventricle (RV), left ventricular (LV)
dysfunction also manifests in the course of primary PH
[32], chronic thromboembolism [13] and cor pulmonale
[41]. Echocardiography-based studies carried out in PH
patients suggested that one of the mechanisms contributing
to LV dysfunction is ventricular interdependence and
impaired LV filling [35]. Other studies, however, provide
evidences that intrinsic LV myocardial abnormalities also
contribute to LV dysfunction in severe PH [11, 12, 24, 33].
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In fact, the LV of rats with severe longstanding PH induced
by monocrotaline (MCT) presents local autocrine/paracrine
system activation and muscle strips dissected from the LV
myocardium show, in vitro, negative force–frequency
relationships (FFR) [33]. Intrinsic LV myocardial abnor-
malities might help to explain late recovery of LV filling
after single-lung transplantation in patients with PH, even
if LV geometry and RV function are immediately restored
[50]. They might explain as well, why combined heart–
lung transplantation is favored for PH patients when severe
impairment of LV function is present, since LV function
may not sufficiently recover after transplantation of the
lungs alone [39].
The timing of development and the underlying mecha-
nisms of intrinsic LV myocardial dysfunction were
incompletely investigated so far. In the present study, we
analyzed biventricular hemodynamics, LV myosin heavy
chain (MHC) protein isoforms, LV myocardial expression
of genes involved in neurohumoral activation (angioten-
sin-converting enzyme and endothelin-1), extracellular
matrix remodelling (tenascin-C gene expression and
interstitial fibrosis) and apoptosis (TUNEL assay), 4 and
6 weeks after MCT injection. Hemodynamics were stud-
ied at baseline and in response to single-beat afterload
elevations, which allow the detection of diastolic dys-
function that may not be evident during evaluation at rest,
but is revealed during exercise or hemodynamic stress [9,
10, 19, 20, 26, 48].
Methods
Animal protocol
The investigation conforms to the Guide for the Care and
Use of Laboratory Animals published by the US National
Institutes of Health (NIH Publication No. 85-23, revised
1996) and the experiments were performed according to
the Portuguese law on animal welfare. Seven-weeks-old
male Wistar rats (n = 58; Charles-River, Barcelona, Spain)
were housed in groups of three per cage in a controlled
environment under a 12:12 h light/dark cycle at a room
temperature of 22C. Rats randomly received, a subcuta-
neous injection of monocrotaline (MCT, 60 mg/kg; Sigma
Chemical, St. Louis, MO, USA; n = 36) or an equal vol-
ume of vehicle (Ctrl, n = 22; 1 mL/kg). Animals had free
supply of food and water. Hemodynamic studies and col-
lection of samples for molecular and histological studies
were carried out, for control and MCT-treated rats, at days
22, 24 or 26 (fourth week), Ctrl-4 (n = 11) and MCT-4
(n = 11), respectively, and at days 36, 38 or 40 (sixth
week) after injection, Ctrl-6 (n = 11) and MCT-6
(n = 11), respectively.
Hemodynamic studies
Experimental preparation
Animals were anesthetized with an intraperitoneal injection
of 60 mg/kg pentobarbital sodium and additional boluses
of 20 mg/kg when needed, placed over a heating pad, and
mechanically ventilated (Harvard Rodent Ventilator model
683) through a tracheostomy. The right jugular vein was
cannulated and a pre-warmed 0.9% NaCl solution was
administrated to compensate for perioperative fluid losses.
The heart was exposed through a median sternotomy and
the pericardium widely opened. The ascending aorta was
dissected and surrounded by a silk thread in order to
transiently occlude it during the experimental protocol. RV
pressure was measured with a 2F high-fidelity micro-
manometer (SPR-324, Millar Instruments, Houston, TX,
USA) inserted through the RV free wall into the RV cavity
and LV pressure with a 3F high-fidelity micromanometer
(SPR-407, Millar Instruments, Houston, TX, USA) inserted
through an apical puncture into the LV cavity. LV septal to
free wall diameter was recorded with ultrasonic crystals
using a sonomicrometer amplifier (Triton Technology, San
Diego, CA, USA). One crystal was placed into the left
border of the interventricular septum and the other on the
epicardial surface of the LV free wall, as previously
described [3, 4]. A limb ECG (II) was recorded throughout.
After the instrumentation period (typically 60 min), the
animal was allowed to stabilize for 15 min before the
beginning of the experimental protocol. Recordings were
made with ventilation suspended at end-expiration.
Parameters were converted on line to digital data with a
sampling frequency of 1,000 Hz.
Data analysis
Peak rates of LV and RV pressure rise (dP/dtmax) and fall (dP/
dtmin) were determined. RV and LV pressures were measured
at end-diastole (EDRVP and EDLVP, respectively) and at
peak-systole (RVPmax and LVPmax). Relaxation rate was
estimated with the time constant s, by fitting isovolumetric
LV pressure fall to a monoexponential function. From base-
line to isovolumetric, multiple graded LV pressure elevations
were randomly performed by abruptly clamping the ascend-
ing aortic root starting in the diastole separating two
heartbeats, as previously described [3, 4, 25, 31]. Beats pre-
ceding aortic obstruction were designated as baseline
heartbeats and those immediately following it as test beats.
Along with the baseline hemodynamics, four afterloaded test-
beats with a peak systolic pressure of approximately 60, 70,
80, and 90 of the isovolumetric pressures, and the isovolu-
metric test-beat were selected for analysis. LV septum to free
wall diameter was measured at end-diastole. Afterload-
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induced shifts of the end-diastolic pressure–dimension rela-
tion (EDPDR) were assessed by measuring diastolic
pressures at matched dimensions, close to end-diastole, as
previously described [3, 4, 29, 30].
At the end of the hemodynamic study animals were
euthanized with anesthetic overdose, the position of crys-
tals and manometers was verified, the RV was carefully
dissected from the interventricular septum and LV free
wall, and transmural samples of LV free wall (excluding
the septum) were collected for molecular studies. Two
MCT-6 rats died during hemodynamic instrumentation,
having been excluded from analysis.
Morphometric determination of cardiac fibrosis
Transverse-sections of paraffin-embedded, formalin-fixed
specimens encompassing the LV free-wall were stained
with Masson’s Trichrome and photographed with a digital
camera (Leica DFC320) in additional animals (n = 5 per
group). A 330-point grid was superimposed on ten
fields (4009) randomly selected on each section. Two
independent blinded observers rated the images and the
area-percent of blue staining, indicative of fibrosis, was
calculated as follows: (total number of blue-positive
points/total number of points) 9 100.
Detection of apoptotic cardiomyocytes
To assess the extent of apoptosis the terminal deoxynu-
cleotidyl-transferase-mediated dUTP nick end-labeling
(TUNEL) assay was used (CardioTACSTM in situ Apop-
tosis Detection Kit, R&D Systems, Minneapolis, MN,
USA). Briefly, after deparaffinization tissue slides were
immersed in phosphate-buffered saline (PBS) pH 7.4 and
then permeabilized with proteinase K for 20 min at room
temperature. Endogenous peroxidase activity was quen-
ched using 5.0% hydrogen peroxide. Then, specimens were
incubated in TdT labeling buffer for 5 min. After that,
slides were incubated with a mix containing the terminal
deoxynucleotidyl transferase (TdT), Mn2? and biotinylated
nucleotides for 1 h at 37C, blocked with stop buffer, and
incubated with streptavidin-HRP for 10 min at room tem-
perature. After washing in PBS, the slides were finally
developed using TACS Blue Label. Nuclear staining by
Nucler Fast Red was performed as counterstaining. Posi-
tive control of the TUNEL assay was generated by staining
by the treatment of the samples with TACS-NucleaseTM
prior to the labeling protocol. Negative control of the
TUNEL assay was confirmed by staining of the heart tissue
in the same manner without TdT. We used three sections
obtained at a distance of 100 lm from each tissue block.
TUNEL-positive cardiomyocytes were counted in at least
50 optical fields (4009) of each specimen. The apoptotic
rate was expressed as a percentage of apoptotic cells of all
cardiomyocytes per field.
Molecular studies
Relative quantification of mRNA
Two-step Real-time RT-PCR was performed as previously
described [14, 15, 33, 40]. Briefly, after total mRNA
extraction (no. 74124, QIAGEN), standard curves were
obtained using graded dilutions of a rat cardiac tissue
sample. The starting mRNA quantities were correlated
(R C 0.98) with the respective threshold cycles, for each
gene. Threshold cycles were automatically calculated by
software (LightCycler, ROCHE) using the second deriva-
tive maximum method. An equal amount of mRNA from
every sample underwent two separate two-step real time
RT-PCR experiments for each gene, using SYBR green as
marker (no. 204143, QIAGEN). Glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) was used as internal
control since its mRNA levels were similar in the studied
groups. Results are normalized for GAPDH and presented
in arbitrary units. The arbitrary unit was set as the mean
obtained for the Ctrl-4 group. Specific PCR primer pairs for
the studied genes were: endothelin-1 (ET-1), fw 50-CCA
TGC AGA AAG GCG TAA AAG-30, rev 50-CGG GGC
TCT GTA GTC AAT GTG-30; angiotensin-converting
enzyme (ACE), fw 50-GCA GGC CAG CAG GGT CCA
CTA CAC-30, rev 50-GAC CTC GCC ATT CCG CTG
ATT CT-30; tenascin-C, fw 50-TCT CCG GTG TAG CCC
TCG TCA-30, rev 50-CAC CAT GGC CGC TGT CTC AA-
30; and GADPH, fw 50-TGG CCT TCC GTG TTC CTA
CCC-30, rev 50-CCG CCT GCT TCA CCA CCT TCT-30.
Relative quantification of myosin heavy-chain isoforms
Total protein (15 lg) was separated by SDS-PAGE (3.0%
stacking and 5.0% running polyacrylamide gels). Electro-
phoresis was carried out at constant voltage (60 V) for
*270 min (no. 165-3301, BIO-RAD), allowing the sepa-
ration of myosin heavy-chain isoforms a and b isoforms in
two distinct bands visible at *200 KDa. Gels were silver-
stained following the manufacturer’s instructions (no. 161-
0449, BIO-RAD) and the relative amount of the myosin
heavy-chain isoforms in each sample was quantified by
densitometry (Multilmage Light Cabinet; ALPHA INNO-
TECH CORPORATION).
Statistical analysis
Values were expressed as mean ± SEM. Differences in
baseline hemodynamic parameters, morphology, and
molecular studies were evaluated by two-way ANOVA.
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Three-way ANOVA was employed to compare data from
graded afterload elevations. Holm–Sidak’s method was
used for multiple comparisons when significant differences
were detected. Statistical significance was assumed at a
two-tailed value of P \ 0.05.
Results
All MCT-6 animals presented clinical signs of congestive
heart failure such as lethargic behavior, ruffled fur,
cachexia, tachypnea and severe breathing effort, pleural
effusion, and ascites. MCT-4 animals behaved similarly to
control animals. Mortality was null in Ctrl-4 and Ctrl-6,
33% in MCT-4 and 70% in MCT-6. No significant dif-
ferences were observed between Ctrl-4 and Ctrl-6 for
morphometric, hemodynamic and molecular parameters.
Baseline hemodynamics and morphometry
MCT treatment resulted in progressively increasing RV
peak-systolic pressures (Fig. 1a). Increased RV pressures
were accompanied by selective RV hypertrophy, as denoted
by the progressive increase of the RV to LV plus inter-
ventricular septum weight ratio (Fig. 1b). RV end-diastolic
pressures were significantly increased in MCT-6 (4.9 ± 1.0
vs. 1.9 ± 0.5, 0.5 ± 0.3, and 1.1 ± 0.6 mmHg, in MCT-4,
Ctrl-4, and Ctrl-6, respectively). Compared with the other
groups, MCT-6 also presented lower body weight and
heart rate (216 ± 9 vs. 287 ± 7, 265 ± 20, and 270 ±
20 beats/min, in MCT-4, Ctrl-4, and Ctrl-6, respectively).
Both systolic (Fig. 2) and diastolic parameters (Fig. 3)
were preserved at baseline in the LV of MCT-4. MCT-6
animals, however, presented low peak LV systolic pressure
and disturbed indexes of both LV contractility (Fig. 2),
such as reduced peak isovolumetric pressures and dP/dtmax,
and LV relaxation (Fig. 3), such as reduced dP/dtmin and
prolonged time constant s. Despite these hemodynamic
disturbances neither the EDLVP nor the EDLVD were
changed (Fig. 3).
Response of diastolic function to afterload elevations
Both MCT-4 and MCT-6 revealed an impaired response of
diastolic function to afterload elevations (Fig. 4). This
figure displays changes in the time constant s (panel A) and
shifts of the EDPDR (panel B) with increasing afterloads.
Effects on s are expressed by the ratio of test to baseline
beats values. Time constant s was differently affected by
afterload in control and in MCT-treated rats. Control ani-
mals responded to afterload elevations with shortening of s
(acceleration of pressure fall) for almost the entire range of
systolic LV pressures, apart from isovolumetric beats that
showed a non-significant change in s. On the contrary,
MCT-treated animals responded to afterload elevations
with a prolongation of s (slowing of pressure fall). This
slowing was observed only with the two highest afterload
levels in MCT-4, while in MCT-6 such slowing was more
pronounced and present over the entire range of systolic
LV pressures. With regard to the EDPDR, in response to
afterload elevations, it remained unaffected in control
animals, but was upward shifted in both MCT-4 and MCT-
6 groups. This upward shift was of similar magnitude in
MCT-4 and MCT-6 (Fig. 4b), but occurred at much lower
systolic LV pressures in the later. Representative pressure–
dimension loops are presented (Fig. 5).
Neurohumoral activation
The expression of genes involved in autocrine/paracrine
systems was upregulated in the LV myocardium of MCT-
treated rats compared with controls (Fig. 6). Angiotensin-
converting enzyme mRNA levels were progressively
Fig. 1 Development of pulmonary hypertension and selective RV
hypertrophy in response to monocrotaline (MCT) injection. a Peak
systolic right ventricular pressures (RVPmax). b Right ventricular (RV)
weight/left ventricular plus interventricular septum (LV ? S) weight
ratio. RVPmax progressively increased in MCT-4 and MCT-6; RV
weight to LV weight ratio also increased in MCT-4 and MCT-6.
P \ 0.05: * vs. Ctrl-4;  vs. Ctrl-6;  vs. MCT-4 (n = 6 in each group)
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increased in MCT-4 and MCT-6, whereas endothelin-1
expression was only elevated in MCT-6.
Apoptosis
Apoptosis was significantly augmented in LV myocardium
of both MCT-4 and MCT-6 groups, as compared with
controls (Fig. 7a). In the representative examples presented
in Fig. 7b apoptotic cardiomyocytes can be easily identi-
fied in MCT groups.
Extracellular matrix composition
Regarding the extracellular matrix composition, we eval-
uated the gene expression of tenascin-C, an extracellular
matrix glycoprotein as well as the LV interstitial collagen
content. Both were significantly increased only in MCT-6
group (Fig. 8).
LV myofilaments
With regard to myofilament composition, a significant
elevation of the relative expression of myosin heavy-chain
b-isoform was observed in both MCT-4 and MCT-6 LV
myocardium compared with Ctrl-4 and Ctrl-6, respectively
(Fig. 9).
Discussion
The present study was undertaken to investigate the onset
and progression of LV dysfunction in the course of PH and
Fig. 2 Left ventricular (LV) systolic hemodynamic parameters. a Peak systolic LV pressure (LVPmax). b Peak isovolumetric LV pressure
(LVPiso). c Peak rate of LV pressure rise (dP/dtmax). P \ 0.05: * vs. Ctrl-4;  vs. Ctrl-6;  vs. MCT-4 (n = 6 in each group)
Fig. 3 Left ventricular (LV)
diastolic hemodynamic
parameters. a End diastolic left
ventricular (LV) pressure
(EDLVP). b End diastolic LV
dimensions (EDLVD). c Peak
rate of LV pressure fall (dP/
dtmin). d LV time constant s.
Significant differences were
found for dP/dtmin and s,
whereas no differences were
observed for EDLVP and
EDLVD. P \ 0.05: * vs. Ctrl-
4;  vs. Ctrl-6;  vs. MCT-4
(n = 6 in each group)
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the underlying myocardial mechanisms, namely neuro-
humoral activation, extracellular matrix composition and
apoptosis. A hemodynamic stress test with single-beat
afterload elevations was used to detect early, load depen-
dent, changes in LV diastolic function in animals with
MCT induced PH.
MCT-treated rats progressively developed PH, as eval-
uated by RVPmax, selective RV myocardial hypertrophy,
and increased EDRVP. As previously reported [33], MCT-
6 rats showed clinical signs of congestive heart failure,
disturbed indexes of LV contractility and relaxation, and
increased expression of ACE and ET-1 in the LV myo-
cardium. A more detailed discussion on the possible causes
of neuroendocrine activation in the non-overloaded LV is
provided elsewhere [33]. MCT-6 animals also presented
reductions in body weight and LVPmax, previously inter-
preted as consequence of continuous severe sickness [36],
as well as, diminished heart rate, suggesting an attenuation
of the sympathetic nervous system response [25, 33]. In
contrast, MCT-4 rats showed no baseline LV hemody-
namic changes. Nonetheless, single afterloaded test-beats
revealed diastolic function impairment in MCT-4. Systolic
performance, as assessed by the contractility indexes
LVPiso and dP/dtmax, was unchanged, but diastolic dys-
function was elicited in response to increased afterload
(afterload-induced diastolic dysfunction; [29, 30]). Diastole
was evaluated with the time constant of isovolumetric
relaxation s and the end-diastolic pressure–diameter rela-
tion (EDPDR), the former evaluates active relaxation while
the latter is an in vivo estimate of myocardial stiffness. The
dynamic process of myocardial relaxation goes on from the
ejection phase to the early filling period. The main hemo-
dynamic manifestation of myocardial relaxation, however,
is LV pressure fall and its analysis, through the time con-
stant s, allows a description of the course of myocardial
relaxation [26]. Changes in afterload modify s and the rate
of LV pressure fall. While in healthy hearts small afterload
elevations accelerate LV pressure fall and only marked
afterload increases slow it, in failing hearts even slight
increases in afterload may induce slower relaxation. At a
similar systolic LV pressure, in failing hearts the relative
load, defined as the ratio of systolic LV pressure to iso-
volumetric LV pressure, is higher, the afterload reserve is
surpassed and afterload mismatch yields a pronounced
slowing of LV pressure fall, compared with healthy hearts
[10, 31].
Diastolic dysfunction is commonly defined, in hemo-
dynamic terms, by an upward displacement of the EDPDR
[26], which reflects a decrease in diastolic distensibility
[13]. Classically, it was held that only chronic conditions
that altered the compliance and distensibility of the LV
could change the filling conditions to the point of modi-
fying the EDPDR. However, more recent work
demonstrated that the EDPDR could be acutely shifted by
load [25, 31] and neurohumoral stimulation [27, 28, 37].
Afterload mismatch induces incomplete myocardial relax-
ation that can be large enough to increase LV pressure at
end-diastole and cause diastolic dysfunction. A slower
course of myocardial relaxation and the decrease in time
available for the ventricle to relax are the major underlying
mechanisms of afterload-induced diastolic dysfunction [29,
Fig. 4 Effects of acute left ventricular (LV) afterload elevations on
LV diastolic function. a Fractional changes in time constant s (stest/
sbaseline). b Upward shift in the end-diastolic pressure–dimension
relation (EDPDR). Six beats with progressively higher peak systolic
LV pressure (LVPmax) are represented: baseline, test-beats with a
peak systolic LV pressure corresponding to 60, 70, 80, and 90% of the
isovolumetric beat, and the isovolumetric test-beat (LVPiso); n = 6 in
each group. MCT-treated rats, distinctly from controls (*P = 0.002),
presented a prolongation of the time constant s in test beats compared
with baseline beat (P \ 0.01), while controls presented an overall
acceleration of relaxation and shortening of s, with the exception of
the isovolumetric test beats. In MCT-6 the changes in s were more
striking and observed for lower afterload levels than in MCT-4
(P = 0.007). The upward shift of EDPDR in test-beats compared
with baseline beat (P \ 0.01) was more pronounced and observed
for lower afterload levels in MCT-treated rats compared with controls
(*P = 0.008)
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30]. Compared with control rats, MCT-treated rats devel-
oped prolongation of time constant s and a larger upward
shift of the EDPDR indicating that afterload mismatch
occurred at lower relative loads. Curiously, although MCT-
6, unlike MCT-4, presented prolongation of s at baseline
that was aggravated with every step up in relative load,
there were no differences between the two groups regard-
ing the upward shift of the EDPDR induced by afterload.
One possible reason is the difference in heart rates. Inap-
propriate increases in heart rate are known to upwardly
displace the EDPDR even if relaxation rate is normal [49].
Conversely, the reduction in the heart rate of MCT-6 may
have partly reverted afterload-dependent diastolic dys-
function by increasing the time available for relaxation and
the extent of relaxation. Animals and patients with PH are
known to respond badly to hemodynamic stress [19, 23,
45]. The present results suggest that increased systemic
blood pressures may induce, or contribute to, hemody-
namic deterioration in PH by leading to, or worsening of,
LV diastolic dysfunction.
One of the most likely subcellular candidates for myo-
cardial dysfunction is the altered myofilament composition.
MCT-treated rats presented myosin heavy-chain isoform
switch in the LV myocardium. The slower b-isoform was
increased in the LV of both MCT-4 and MCT-6, as pre-
viously reported in different models of RV hypertrophy
[17, 43, 46, 47]. Changes in the expression of enzymes
involved in bioenergetics and cell metabolism such as
pyruvate dehydrogenase kinase-4, acetyl-CoA dehydroge-
nase and mitochondrial ATP synthase [42, 43] as well as a
reduced capillary proliferation [21] have also been descri-
bed in the LV of PH rats. Contrastingly, calcium kinetics
Fig. 5 Representative examples of left ventricular pressure-dimen-
sion (LVPD) loops of a Ctrl-4 (left), a MCT-4 (centre) and a MCT-6
(right) animal at increasing afterload levels, from baseline up to
isovolumetric. Peak systolic pressures are similar in Ctrl-4 and MCT-4
animals, but are clearly decreased in the MCT-6 animal. On the other
side, diastolic pressures are nicely matched at all afterload levels in
the control animal, but become progressively higher as afterload
increases, both in MCT-4 and MCT-6 animals. As Ctrl-4 and Ctrl-6
animals were entirely similar only a representative example of Ctrl-4
is given
Fig. 6 Left ventricular (LV) mRNA levels of angiotensin-converting
enzyme (ACE; a) and endothelin-1 (ET-1; b) in rats with monocro-
taline (MTC)-induced pulmonary hypertension (MCT-4, n = 6;
MCT-6, n = 6) and controls (Ctrl-4, n = 6; Ctrl-6, n = 6), 4 and
6 weeks after injection, respectively. Results are expressed as
arbitrary units after normalization for GAPDH. The arbitrary unit
was set as the average value of the Ctrl-4 group. ACE mRNA levels
progressively increased in MCT-4 and MCT-6, whereas ET-1 mRNA
levels were only increased 6 weeks after MCT injection P \ 0.05: *
vs. Ctrl-4;  vs. Ctrl-6;  vs. MCT-4
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regulator proteins such as the Ca2?-ATPase of the sarco-
endoplasmic reticulum and phospholamban were
consistently reported to be unaltered in the non-overloaded
LV [21, 42, 43]. To further explore the underlying mech-
anisms of LV myocardial dysfunction, we investigated
neurohumoral activation, extracellular matrix composition
and apoptosis.
Regarding local autocrine/paracrine related gene
expression, MCT-4 rats showed increased ACE mRNA
levels in the LV myocardium. However, only MCT-6 rats
presented markedly increased expression of ET-1, and
ACE was further upregulated compared with MCT-4. The
activation of autocrine/paracrine systems, particularly for
ET-1, was concomitant with the development of LV sys-
tolic and diastolic dysfunction in the baseline
hemodynamic evaluation. It has been suggested that
cardiac ET-1 may play a critical role in the functional
deterioration of LV during the transition to congestive
heart failure [18]. Indeed, chronic administration of ET-1,
for 5 days, to engineered heart tissues, derived from cells
of neonatal rat hearts, decreased the contractile response to
calcium and isoprenaline and changed myosin heavy chain
isoform and sarcoendoplasmic reticulum Ca2?-ATPase
expression in a signaling pathway that involved protein
kinase-C and the Na?/H? exchanger [51]. Lower heart
rate, LVPmax and LV dysfunction under the stress of
anesthesia and surgical manipulation could well be partly
the consequence of refractoriness to adrenergic stimulation
mentioned above. Further supporting the possibility that
ET-1 might have an important role modulating LV function
in PH we have previously demonstrated that chronic ET-1
blockade prevents functional deterioration of the LV
Fig. 7 Left ventricular (LV)
apoptosis is expressed as
TUNEL-positive cell
percentage (a). There is a
significant increase in apoptosis
in both MCT-4 and MCT-6
groups (P \ 0.05: * vs. Ctrl-4; 
vs. Ctrl-6). Representative
examples from rats with
monocrotaline-induced
pulmonary hypertension (MCT)
and controls (Ctrl) 4 and
6 weeks after injection are
presented in b (arrows apoptotic
cells)
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myocardium in PH rats, restoring normal contractile
response to increasing frequencies of stimulation [33].
A possible molecular mechanism involved in the left
ventricular dysfunction that accompanied severe PH is
altered extracellular matrix composition and fibrillar col-
lagen content [6, 8, 38]. Tenascin-C is synthesized by
fibroblasts, highly expressed in embryonic tissues, and
upregulated by both mechanical stress [2] and neuroendo-
crine mediators [34] in adult tissues under pathological
conditions such as myocardial infarction [16]. Additionally,
several pro-inflammatory cytokines, growth factors and
neurohumoral peptides that stimulate tenascin-C synthesis
[8, 34, 42] also participate in myocardial dysfunction
induced by MCT [6, 33]. Tenascin-C is an important
regulator of extracellular matrix and induces several
metalloproteinases which activation is implicated in cardiac
remodeling [44]. In the present study, we could demonstrate
Fig. 8 Left ventricular (LV)
mRNA levels of tenascin-C
expressed as arbitrary units after
normalization for GAPDH (a)
was increased in MCT-6 group
(P \ 0.05: * vs. Ctrl-6;  vs.
MCT-4). Collagen area fraction
was increased in MCT-6 group
(P \ 0.05: * vs. Ctrl-6) (b).
Representative examples of left
ventricle myocardium stained
with Masson’s Trichrome of
rats with monocrotaline-induced
pulmonary hypertension (MCT)
and controls (Ctrl) 4 and
6 weeks after injection, are
presented in c
Fig. 9 Myosin heavy chain (MHC) isoform switch in monocrotaline-
induced pulmonary hypertension, manifested as a significant increase
of the b-MHC isoform that was similar in the MCT-4 and MCT-6
groups. P \ 0.05: * vs. Ctrl-4;  vs. Ctrl-6 (n = 6 in each group)
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that there is a significant increase in myocardial interstitial
collagen content and tenascin-C gene expression only
6 weeks after MCT injection, suggesting that changes in
extracellular matrix composition may partly underlie the
late deterioration of LV function in MCT-induced PH.
There are evidences suggesting that cell cycle and
apoptosis pathways are co-activated in pressure-overload
RV in MCT model [5]. In this sequence, we assessed the
LV myocardial apoptosis, and found increased rates of
apoptosis both in MCT-4 and MCT-6. Although there is
some controversy about the role of apoptosis in chronic
heart failure [1, 7, 22], this results suggest that it might be
another possible mechanism involved in early events of LV
dysfunction.
In conclusion, selectively RV overloaded MCT-treated
rats develop, on hemodynamic assessment, LV dysfunction
that is accompanied by myosin heavy-chain isoform switch
and local LV autocrine/paracrine system activation.
Despite the changes in myocardial molecular phenotype,
such as MHC isoform switch, increased apoptosis and ACE
upregulation, in the LV, 4 weeks after MCT injection,
diastolic dysfunction can only be detected in MCT-4 by
increasing afterload. Two weeks later, however, the LV
myocardium of MCT-6 overexpresses ET-1 has increased
collagen content and augmented gene expression of ten-
ascin-C and presents baseline systolic and diastolic
dysfunction. The transition to LV dysfunction and con-
gestive heart failure in PH is a complex process that
involves the activation of several subcellular pathways.
Afterload-dependent diastolic disturbances of the LV may
herald, or contribute to, hemodynamic deterioration in PH.
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